Latest News
UnitedHealth Dips 1.5% as Minor Fund Filings Shed Little Light
UnitedHealth shares dropped 1.5% Monday, with newly disclosed fund filings covering just 0.006% of outstanding shares. Volume lagged 31% below average, while Q2 earnings beat expectations.
JCPenney's $15 Trade-In Deal Puts Off-Price Rivals on Alert
JCPenney's new $15 trade-in offer (Aug 28-30) targets off-price shoppers, but rivals like Ross (down 4.1%) remain strong. Analysts question long-term impact.
INVO Fertility Stock Soars 60% on Unprecedented Trading Volume
INVO Fertility (IVF) rocketed 60% on Monday with volume 1,500 times its average, despite no corporate announcement. The stock closed at $1.53 after touching $2.80, with fundamentals still under pressure.
Rocket Stock Slips 2.6% as Modest Rate Cut Offers Little Relief
Rocket Companies shares dropped 2.6% as a 7-basis-point decline in 30-year mortgage rates cuts a typical monthly payment by only $16, underscoring limited near-term housing relief.
Albertsons trims store count as profit plunges 64%
Albertsons (ACI) is closing 12 stores, representing 0.5% of its footprint, after a 64% plunge in net income and reduced full-year guidance.
Target's 56% Rally Faces Earnings Hurdle as Analysts See Limited Upside
Target (TGT) shares have rallied 56% in 2026, now trading above analyst consensus targets. The market awaits Q2 earnings to confirm sustainable growth, not just a low-base benefit.
Cemex Stock Gains on Peso Strength, Currency Tailwind Seen at 8%
Cemex (NYSE:CX) benefits as the peso approaches 17 per dollar, an 8% currency translation gain vs. guidance. Q2 EBITDA rose 24%, free cash flow tripled.
Valero Stock Rally Stalls as Diesel Margins Hit Record $93.84
Diesel margins hit a record $93.84, boosting Valero's earnings, but the stock rally may be overextended as it trades above most price targets.
Meta Faces $1.4 Trillion Legal Claim as Youth-Safety Trial Opens
Meta Platforms (META) begins a landmark youth-safety trial with states seeking up to $1.4 trillion in damages, a sum 15.5 times its cash reserves. Legal costs already hit Q2 profits.
RTX Lands $22.9B Tomahawk Deal, But Scaling Output Poses Challenge
RTX's $22.9B Tomahawk contract boosts backlog but requires a 17x production increase, raising margin concerns. Stock barely moved as investors weigh long-term execution.
Vivmark Residential Debuts as EQR Slips 2.3%, AVB Holders See $4 Hit
Equity Residential shares dropped 2.3% to $64.47 after the AvalonBay merger created Vivmark Residential. Former AVB holders saw an implied value of $180.06 per share, $4 below Friday's close.